Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;5(3):273-80.
doi: 10.1016/j.molonc.2011.02.003. Epub 2011 Feb 24.

miRNA expression profiling of mycosis fungoides

Marloes S van Kester  1 , Erica Ballabio, Marchina F Benner, Xiao H Chen, Nigel J Saunders, Leslie van der Fits, Remco van Doorn, Maarten H Vermeer, Rein Willemze, Cornelis P Tensen, Charles H Lawrie
Affiliations

miRNA expression profiling of mycosis fungoides

Marloes S van Kester et al. Mol Oncol. 2011 Jun.

Abstract

MicroRNAs (miRNAs) are small RNA species that regulate gene expression post-transcriptionally and are aberrantly expressed in many malignancies including lymphoma. However, the role of miRNAs in the pathogenesis of T-cell lymphoid malignancies is poorly understood. Previously we examined the miRNA profile of Sézary syndrome (Sz), a leukemia of skin-homing memory T cells. In this study we determined the complete miRNome of mycosis fungoides (MF), the most common type of cutaneous T cell lymphoma. The miRNA profile of skin biopsies from 19 patients with tumor stage MF and 12 patients with benign inflammatory dermatoses (eczema and lichen planus) were compared by microarray analysis. We identified 49 miRNAs that are differentially expressed in tumor stage MF compared to benign inflammatory dermatoses using ANOVA analysis (P < 0.05, Benjamini-Hochberg corrected). The majority of the differentially expressed miRNAs (30/49) were up-regulated in tumor stage MF. The most significant differentially expressed were miR-155 and miR-92a (both up-regulated in tumor stage MF), while miR-93 showed the highest up-regulation in tumor stage MF with a fold difference of 5.8. Differential expression of a selection of these miRNAs was validated by miRNA-Q-PCR on additional test groups (tumors and controls). None of the miRNAs up-regulated in tumor stage MF was previously shown to be up-regulated in Sz, and only 2 of the 19 miRNAs down-regulated in tumor stage MF were also down-regulated in Sz. Taken together this report is the first describing the miRNA signature of tumor stage MF.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Unsupervised cluster analysis tumor stage MF and benign inflammatory dermatoses. Heatmap representing miRNA array expression data of MF tumor samples (n = 19 depicted in blue) and benign inflammatory dermatosis samples (n = 12, depicted in yellow).
Figure 2
Figure 2
Expression levels of selected miRNAs as measured by miRNA‐Q‐PCR in an additional test group. Expression levels of miR‐93, miR‐155, miR‐92a, miR‐30b, miR‐16, miR‐30c and miR‐383 in tumor stage MF (n = 10) and benign inflammatory dermatoses (Lichen planus n = 6, Eczema n = 5) calculated by Delta Ct method. Horizontal bars represent the mean. All miRNAs are significant differentially expressed between tumor stage MF and benign inflammatory dermatoses, p‐values were measured by Mann–Whitney independent t test.
See this image and copyright information in PMC

References

    1. Ballabio, E. , Mitchell, T. , van Kester, M.S. , Taylor, S. , Dunlop, H.M. , Chi, J. , Tosi, I. , Vermeer, M.H. , Tramonti, D. , Saunders, N.J. , Boultwood, J. , Wainscoat, J.S. , Pezzella, F. , Whittaker, S.J. , Tensen, C.P. , Hatton, C.S. , Lawrie, C.H. , 2010. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood. 116, 1105–1113. - PMC - PubMed
    1. Bonauer, A. , Dimmeler, S. , 2009. The microRNA-17-92 cluster: still a miRacle?. Cell Cycle. 8, 3866–3873. - PubMed
    1. Booken, N. , Gratchev, A. , Utikal, J. , Weiss, C. , Yu, X. , Qadoumi, M. , Schmuth, M. , Sepp, N. , Nashan, D. , Rass, K. , Tuting, T. , Assaf, C. , Dippel, E. , Stadler, R. , Klemke, C.D. , Goerdt, S. , 2008. Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Leukemia. 22, 393–399. - PubMed
    1. Calin, G.A. , Croce, C.M. , 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer. 6, 857–866. - PubMed
    1. Calin, G.A. , Croce, C.M. , 2006. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene. 25, 6202–6210. - PubMed

Publication types